Hal D. Martin

Statistics

Publications

Citations

135

H-Index

Active since

2012

Affiliations

Gilead Sciences (United States)(Current)

Hal D. Martin is an author at Gilead Sciences (United States) specializing in clinical pharmacology, randomized crossover trials, and randomized clinical trials.

Publications per year

2012–2024

Publications

Bictegravir/emtricitabine/tenofovir alafenamide as initial treatment for HIV-1: five-year follow-up from two randomized trials

Paul E. Sax, José Ramón Arribas, Chloe Orkin et al. · EClinicalMedicine · 2023 · 85 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Physiological Changes as a Result of Hip Arthroscopy Performed With Traction

Hal D. Martin, Ian Palmer, Keith Champlin et al. · Arthroscopy The Journal of Arthroscopic and Related Surgery · 2012 · 38 citations

Medicine, Orthopaedic Surgery, Orthopedic Surgery +14

High efficacy of bictegravir/emtricitabine/tenofovir alafenamide (B/F/TAF) in Black adults in the United States, including those with pre‐existing HIV resistance and suboptimal adherence

Kristen Andreatta, Michelle L. D’Antoni, Silvia Chang et al. · Journal of Medical Virology · 2024 · 12 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

1–3 of 3